IDEXX LABORATORIES INC /DE Increase (Decrease) in Contract with Customer, Liability
IDEXX LABORATORIES INC /DE (IDXX) reported Increase (Decrease) in Contract with Customer, Liability of $6.93 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-20.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInContractWithCustomerLiability · last filed 2026-02-20
- IDEXX LABORATORIES INC /DE increase (decrease) in contract with customer, liability for the quarter ending 2025-12-31 was $713.00K.
- IDEXX LABORATORIES INC /DE increase (decrease) in contract with customer, liability for the quarter ending 2025-09-30 was -$230.00K.
- IDEXX LABORATORIES INC /DE increase (decrease) in contract with customer, liability for the quarter ending 2025-06-30 was $5.61M.
- IDEXX LABORATORIES INC /DE increase (decrease) in contract with customer, liability for the quarter ending 2025-03-31 was $838.00K, a 19.20% increase year-over-year.
- IDEXX LABORATORIES INC /DE increase (decrease) in contract with customer, liability for fiscal 2025 was $6.93M.
- IDEXX LABORATORIES INC /DE increase (decrease) in contract with customer, liability for fiscal 2024 was -$4.38M.
- IDEXX LABORATORIES INC /DE increase (decrease) in contract with customer, liability for fiscal 2023 was -$3.03M.
- IDEXX LABORATORIES INC /DE increase (decrease) in contract with customer, liability for fiscal 2022 was -$11.02M.
| Period end | Increase (Decrease) in Contract with Customer, Liability 3 month | Increase (Decrease) in Contract with Customer, Liability 6 month | Increase (Decrease) in Contract with Customer, Liability 9 month | Increase (Decrease) in Contract with Customer, Liability 12 month |
|---|---|---|---|---|
| 2025-12-31 | $713.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | $483.00K derived: sum of 2 quarters · filed 2026-02-20 | $6.09M derived: sum of 3 quarters · filed 2026-02-20 | $6.93M 10-K · filed 2026-02-20 |
| 2025-09-30 | -$230.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | $5.38M derived: sum of 2 quarters · filed 2025-11-03 | $6.22M 10-Q · filed 2025-11-03 | $2.57M derived: sum of 4 quarters · filed 2026-02-20 |
| 2025-06-30 | $5.61M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | $6.45M 10-Q · filed 2025-08-04 | $2.80M derived: sum of 3 quarters · filed 2026-02-20 | $2.59M derived: sum of 4 quarters · filed 2026-02-20 |
| 2025-03-31 | $838.00K 10-Q · filed 2025-05-01 | -$2.81M derived: sum of 2 quarters · filed 2026-02-20 | -$3.01M derived: sum of 3 quarters · filed 2026-02-20 | -$4.24M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-12-31 | -$3.64M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$3.85M derived: sum of 2 quarters · filed 2026-02-20 | -$5.08M derived: sum of 3 quarters · filed 2026-02-20 | -$4.38M 10-K · filed 2026-02-20 |
| 2024-09-30 | -$209.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-03 | -$1.44M derived: sum of 2 quarters · filed 2025-11-03 | -$735.00K 10-Q · filed 2025-11-03 | -$420.00K derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-06-30 | -$1.23M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | -$526.00K 10-Q · filed 2025-08-04 | -$211.00K derived: sum of 3 quarters · filed 2026-02-20 | -$1.70M derived: sum of 4 quarters · filed 2026-02-20 |
| 2024-03-31 | $703.00K 10-Q · filed 2025-05-01 | $1.02M derived: sum of 2 quarters · filed 2026-02-20 | -$474.00K derived: sum of 3 quarters · filed 2026-02-20 | -$1.72M derived: sum of 4 quarters · filed 2026-02-20 |
| 2023-12-31 | $315.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-20 | -$1.18M derived: sum of 2 quarters · filed 2026-02-20 | -$2.42M derived: sum of 3 quarters · filed 2026-02-20 | -$3.03M 10-K · filed 2026-02-20 |
| 2023-09-30 | -$1.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | -$2.74M derived: sum of 2 quarters · filed 2024-10-31 | -$3.35M 10-Q · filed 2024-10-31 | -$10.95M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-06-30 | -$1.25M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$1.85M 10-Q · filed 2024-08-06 | -$9.46M derived: sum of 3 quarters · filed 2025-02-21 | -$10.53M derived: sum of 4 quarters · filed 2025-02-21 |
| 2023-03-31 | -$609.00K 10-Q · filed 2024-05-01 | -$8.21M derived: sum of 2 quarters · filed 2025-02-21 | -$9.28M derived: sum of 3 quarters · filed 2025-02-21 | -$10.69M derived: sum of 4 quarters · filed 2025-02-21 |
| 2022-12-31 | -$7.60M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-21 | -$8.68M derived: sum of 2 quarters · filed 2025-02-21 | -$10.08M derived: sum of 3 quarters · filed 2025-02-21 | -$11.02M 10-K · filed 2025-02-21 |
| 2022-09-30 | -$1.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$2.48M derived: sum of 2 quarters · filed 2023-11-01 | -$3.42M 10-Q · filed 2023-11-01 | -$3.48M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | -$1.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | -$2.34M 10-Q · filed 2023-08-01 | -$2.41M derived: sum of 3 quarters · filed 2024-02-22 | -$4.86M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | -$937.00K 10-Q · filed 2023-05-02 | -$1.00M derived: sum of 2 quarters · filed 2024-02-22 | -$3.45M derived: sum of 3 quarters · filed 2024-02-22 | -$6.20M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | -$64.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | -$2.51M derived: sum of 2 quarters · filed 2024-02-22 | -$5.26M derived: sum of 3 quarters · filed 2024-02-22 | -$7.55M 10-K · filed 2024-02-22 |
| 2021-09-30 | -$2.45M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | -$5.20M derived: sum of 2 quarters · filed 2022-11-01 | -$7.49M 10-Q · filed 2022-11-01 | -$10.43M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-06-30 | -$2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | -$5.04M 10-Q · filed 2022-08-02 | -$7.98M derived: sum of 3 quarters · filed 2023-02-16 | -$11.71M derived: sum of 4 quarters · filed 2023-02-16 |
| 2021-03-31 | -$2.29M 10-Q · filed 2022-05-04 | -$5.23M derived: sum of 2 quarters · filed 2023-02-16 | -$8.96M derived: sum of 3 quarters · filed 2023-02-16 | -$13.25M derived: sum of 4 quarters · filed 2023-02-16 |
| 2020-12-31 | -$2.94M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16 | -$6.68M derived: sum of 2 quarters · filed 2023-02-16 | -$10.96M derived: sum of 3 quarters · filed 2023-02-16 | -$13.37M 10-K · filed 2023-02-16 |
| 2020-09-30 | -$3.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | -$8.02M derived: sum of 2 quarters · filed 2021-11-02 | -$10.43M 10-Q · filed 2021-11-02 | -$11.97M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-06-30 | -$4.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-30 | -$6.70M 10-Q · filed 2021-07-30 | -$8.23M derived: sum of 3 quarters · filed 2022-02-16 | -$12.21M derived: sum of 4 quarters · filed 2022-02-16 |
| 2020-03-31 | -$2.41M 10-Q · filed 2021-05-04 | -$3.94M derived: sum of 2 quarters · filed 2022-02-16 | -$7.92M derived: sum of 3 quarters · filed 2022-02-16 | -$11.67M derived: sum of 4 quarters · filed 2022-02-16 |
| 2019-12-31 | -$1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | -$5.51M derived: sum of 2 quarters · filed 2022-02-16 | -$9.26M derived: sum of 3 quarters · filed 2022-02-16 | -$12.36M 10-K · filed 2022-02-16 |
| 2019-09-30 | -$3.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | -$7.73M derived: sum of 2 quarters · filed 2020-10-29 | -$10.83M 10-Q · filed 2020-10-29 | -$12.23M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-06-30 | -$3.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-31 | -$6.85M 10-Q · filed 2020-07-31 | -$8.25M derived: sum of 3 quarters · filed 2021-02-12 | -$11.32M derived: sum of 4 quarters · filed 2021-02-12 |
| 2019-03-31 | -$3.10M 10-Q · filed 2020-04-30 | -$4.50M derived: sum of 2 quarters · filed 2021-02-12 | -$7.57M derived: sum of 3 quarters · filed 2021-02-12 | -$9.49M derived: sum of 4 quarters · filed 2021-02-12 |
| 2018-12-31 | -$1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-12 | -$4.47M derived: sum of 2 quarters · filed 2021-02-12 | -$6.39M derived: sum of 3 quarters · filed 2021-02-12 | -$7.72M 10-K · filed 2021-02-12 |
| 2018-09-30 | -$3.06M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-31 | -$4.99M derived: sum of 2 quarters · filed 2019-10-31 | -$6.31M 10-Q · filed 2019-10-31 | -$5.04M derived: sum of 4 quarters · filed 2020-02-14 |
| 2018-06-30 | -$1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-01 | -$3.25M 10-Q · filed 2019-08-01 | -$1.98M derived: sum of 3 quarters · filed 2020-02-14 | |
| 2018-03-31 | -$1.33M 10-Q · filed 2019-05-01 | -$55.00K derived: sum of 2 quarters · filed 2020-02-14 | ||
| 2017-12-31 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14 | $3.55M 10-K · filed 2020-02-14 | ||
| 2017-09-30 | $2.28M 10-Q · filed 2018-11-01 | |||
| 2016-12-31 | $7.67M 10-K · filed 2019-02-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |